IDEAS home Printed from https://ideas.repec.org/p/hal/journl/halshs-04028255.html
   My bibliography  Save this paper

A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology

Author

Listed:
  • Sophie Boutillier

    (ISI - Centre de recherche sur l’Innovation et les Stratégies Industrielles - ULCO - Université du Littoral Côte d'Opale)

  • Blandine Laperche

    (ISI - Centre de recherche sur l’Innovation et les Stratégies Industrielles - ULCO - Université du Littoral Côte d'Opale)

  • Didier Lebert

    (UEA - Unité d'Économie Appliquée - ENSTA Paris - École Nationale Supérieure de Techniques Avancées - IP Paris - Institut Polytechnique de Paris, i3-CRG - Centre de recherche en gestion i3 - X - École polytechnique - IP Paris - Institut Polytechnique de Paris - IP Paris - Institut Polytechnique de Paris - I3 - Institut interdisciplinaire de l’innovation - CNRS - Centre National de la Recherche Scientifique)

  • Sana Elouaer-Mrizak

    (ISI - Centre de recherche sur l’Innovation et les Stratégies Industrielles - ULCO - Université du Littoral Côte d'Opale)

Abstract

Whereas most of technological trajectory research in evolutionary economics focuses on the sectoral level, our objective is to propose an analysis at the scale of the company. We are studying the leading pharmaceutical company Sanofi and focusing on the development of its vaccine technologies, a very topical issue in the Covid-19 context. What are the characteristics of Sanofi's vaccine technology trajectory and how can they explain the company's position in the Covid-19 crisis, i.e. its ability (or not) to innovate and respond to social demand for a vaccine? We contribute to technological trajectory literature by integrating a systemic dimension of the links between source and destination technology. Our ‘Knowledge Capital Approach' is based on patent citation data and network analysis. It has allowed us to identify the trajectory of Sanofi's vaccine technical system and to show its central position in its knowledge capital, where the technologies mastered by the company converge. These results can be viewed as paradoxical when considering Sanofi's lag in the Covid-19 race for a new vaccine. Our historical and qualitative approach adds to these findings by showing the role of strategic and institutional factors in explaining this situation.

Suggested Citation

  • Sophie Boutillier & Blandine Laperche & Didier Lebert & Sana Elouaer-Mrizak, 2023. "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Post-Print halshs-04028255, HAL.
    • Handle: RePEc:hal:journl:halshs-04028255
    DOI: 10.1016/j.technovation.2023.102746
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rathi, Sawan & Majumdar, Adrija & Chatterjee, Chirantan, 2024. "Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data," Technological Forecasting and Social Change, Elsevier, vol. 198(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:halshs-04028255. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.